Monetizing Minors: Eric Befumo (aka Big Justice)
Brand partnerships worthy of a big “doom!”
Actos
In May 2018, a class-action lawsuit was filed against two marketers of the diabetes medication Actos for allegedly misleadingly marketing the drug as safe and effective without disclosing the risks associated with taking the drug, including bladder cancer and congestive heart failure. (Fernandez et al v. Takeda Pharmaceuticals America, Inc. and Eli Lilly & Company, Case No. 18-cv-1142, E.D. Cal.)
The Latest
Instacart’s AI-Enabled Pricing Experiments May Be Inflating Your Grocery Bill, CR and Groundwork Collaborative Investigation Finds
Derek Kravitz, Consumer Reports
Most Deceptive Ads of 2025
Here were some of the worst ads TINA.org investigated this year.
Cartice
Watch out for this company’s sketchy sale.
Worst False Ad Settlements of 2025
Some class-action settlements that left consumers out in the cold.